Table 5.
Dosimetric parameters after primary (p) and secondary (s) implantation
| Patient number | D90p [%] | V50 [cm3] | V100 [cm3] | V150 [cm3] | V100p [cm3] | V150p [cm3] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
p |
s |
p |
s |
p |
s |
p |
s |
p |
s |
p |
s |
| 1 |
62.8 |
104.4 |
106.5 |
126.4 |
52.6 |
62.7 |
32.6 |
37.6 |
25.5 |
34.1 |
19.5 |
25.5 |
| 2 |
67.6 |
140.2 |
160.9 |
215.6 |
76.7 |
106.9 |
45.8 |
66.4 |
23.4 |
30.7 |
16.1 |
26.3 |
| 3 |
57.2 |
123.5 |
112.7 |
161.2 |
55.4 |
82.4 |
32.9 |
51.0 |
27.5 |
39.4 |
19.0 |
32.2 |
| 4 |
77.0 |
107.9 |
110.5 |
132.5 |
47.7 |
65.0 |
20.1 |
40.1 |
32.4 |
29.3 |
14.6 |
22.9 |
| 5 |
61.7 |
95.9 |
130.1 |
162.5 |
59.8 |
81.7 |
31.7 |
42.7 |
26.4 |
37.4 |
13.3 |
19.5 |
| Median control | 105.4 | 142.7 | 70.5 | 41.7 | 36.9 | 27.3 | ||||||
(D90p – the percentage of the prescribed dose covering 90% of the prostate volume, V50, V100, V150 – the volume receiving 50%, 100% and 150% of the prescribed dose respectively, V100p, V150 – the volume of the prostate in cm3 receiving 100% and 150% of the prescribed dose respectively).
The median values of a control group of 165 consecutive patients was added as control.